As cysteine stabilises CDO levels, cells that express high levels of NRF2 are sensitive to CDO-related toxicity
Monitoring combination effects Additive vs synergistic outcomes: Additive means effects sum (peptide A provides 30% benefit, peptide B provides 30%, combination provides 60%)
Knowing the patients G6PD status is particularly important if the patient is in a high-risk group, as our patient was due to his African heritage
We also hope tirzepatide is accessible to patients who need it, and that providers will discuss other treatment options for the management of OSA along with lifestyle interventions when appropriate
As a result, many people may have suboptimal levels of this critical antioxidant, leading to increased susceptibility to oxidative stress, chronic inflammation, and a higher risk of chronic diseases